Brief Title
Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
Official Title
Collection of Blood and Cerebrospinal Fluid for Pediatric Brain Tumor Research
Brief Summary
In normal patients, blood and cerebrospinal fluid (CSF) contain circulating cells and other molecules such as proteins and nucleic acids. In patients with central nervous system (CNS) and other conditions, the levels of these molecules may be altered. In several other studies at our institution, the investigators are investigating such molecules in tumor specimens as well as the blood and cerebrospinal fluid of pediatric patients with CNS tumors. However, these levels are difficult to interpret without comparing them to levels in patients without CNS tumors. The investigators propose a study to collect small amounts of blood and cerebrospinal fluid from pediatric patients without CNS tumors who are undergoing a diagnostic or therapeutic neurosurgical procedure aimed at addressing altered CSF dynamics.
Study Type
Observational
Primary Outcome
levels of miRNAs in the blood and CSF
Secondary Outcome
Survivin and biologic markers levels in the CSF and blood
Condition
Hydrocephalus
Study Arms / Comparison Groups
Children without central nervous system tumors
Description: Children without central nervous system tumors between the ages of 1 year and 21 years who are undergoing a neurosurgical procedure to address hydrocephalus
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
5
Start Date
July 2011
Completion Date
April 2012
Primary Completion Date
April 2012
Eligibility Criteria
Inclusion Criteria: - Children without central nervous system tumors who are undergoing a neurosurgical procedure to address hydrocephalus during which CSF will be obtained - Between the ages of 1 year and 21 years - Patients must be having blood draws, lumbar punctures or CSF sampling from Ommaya reservoirs or VPS as part of routine clinical care. Exclusion Criteria: - Patients who do not require routine blood draws and/or CSF collection as part of their routine clinical care - Patients who are considered too ill to participate as determined by their treating physician - Patients with documented bacterial of viral infections of the CSF, brain parenchyma and/or neurosurgical devices and/or - Patients with suspected de-myelinating conditions - Patients who are pregnant or lactating.
Gender
All
Ages
1 Year - 21 Years
Accepts Healthy Volunteers
No
Contacts
Rishi Lulla, MD, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT01556178
Organization ID
2011-14612
Responsible Party
Principal Investigator
Study Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Study Sponsor
Rishi Lulla, MD, Principal Investigator, Ann & Robert H Lurie Children's Hospital of Chicago
Verification Date
February 2016